Shifting the PARADIGM: PrimeC a Phase 2b Trial

Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial

Don’t miss this opportunity to hear first hand from these extraordinary individuals as they share their experiences, insights, and aspirations in the pursuit of advancing ALS research. Together, let’s harness the power of citizen research to make a lasting impact on the future of ALS treatments and support.

The meeting will be Wednesday, Nov 20, 2024 at 4:00 pm Pacific Time

• 5:00pm Mountain Time
• 6:00pm Central Time
• 7:00pm Eastern Time

Join the call early!

• The speaker will start promptly at 4:00 PM PST.
• The meeting room will be open at 3:30 PM PST.

Questions for our Speakers?

If you have questions you want to ask during the call, please email info@everythingals.org